These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 20375806

  • 21. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Zivanovic O, Leitao MM, Park KJ, Zhao H, Diaz JP, Konner J, Alektiar K, Chi DS, Abu-Rustum NR, Aghajanian C.
    Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
    [Abstract] [Full Text] [Related]

  • 22. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M, Huang L, Liu JH, Xiong Y, Li JD, Huang X, He L, Ren YF, Wang HY.
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
    Mabuchi S, Okazawa M, Kinose Y, Matsuo K, Fujiwara M, Suzuki O, Morii E, Kamiura S, Ogawa K, Kimura T.
    Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
    [Abstract] [Full Text] [Related]

  • 24. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T, Wu L, Xing H, Yang R, Li X, Huang K, Jia Y, Zhang Q, Chen Z, Wang S, Liu D, Han X, Lin Z, Qu P, Cai H, Song X, Tian X, Wang H, Wang S, Xie X, Li S, Ma D.
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [Abstract] [Full Text] [Related]

  • 25. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [Abstract] [Full Text] [Related]

  • 26. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY, Zhang YN, Liu JG.
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [Abstract] [Full Text] [Related]

  • 27. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B, Patil B, Deodhar KK, Maheshwari A, A Kerkar R, Gupta S, Tongaonkar HB, Shrivastava SK.
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [Abstract] [Full Text] [Related]

  • 28. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study.
    Lee KB, Lee JM, Park CY, Lee KB, Cho HY, Ha SY.
    Int J Gynecol Cancer; 2006 Feb; 16(4):1569-73. PubMed ID: 16884367
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinicopathologic study of patients with small cell carcinoma of the cervix].
    Guo T, Li C, Guo H.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):91-3. PubMed ID: 11809107
    [Abstract] [Full Text] [Related]

  • 34. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
    Kwon J, Eom KY, Kim YS, Park W, Chun M, Lee J, Kim YB, Yoon WS, Kim JH, Choi JH, Chang SK, Jeong BK, Lee SH, Cha J.
    Cancer Res Treat; 2018 Jul; 50(3):964-974. PubMed ID: 29081219
    [Abstract] [Full Text] [Related]

  • 35. Contributing factors for bone metastasis in uterine cervical cancer.
    Yoon A, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    Int J Gynecol Cancer; 2013 Sep; 23(7):1311-7. PubMed ID: 23839246
    [Abstract] [Full Text] [Related]

  • 36. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P, Tripcony L, Nicklin J.
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [Abstract] [Full Text] [Related]

  • 37. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.